Thomas Graham's Kahn Brothers Group Portfolio Shows Mixed Quarterly Performance
Thomas Graham's portfolio at Kahn Brothers Group experienced slight decreases in some holdings while showing increases in others during the quarter, maintaining a diverse allocation across sectors.
Thomas Graham, managing the portfolio at Kahn Brothers Group, held a total portfolio value of $564.7 million as of December 31, 2025.
The portfolio allocation featured significant positions in major corporations. Citigroup Inc (C) maintained its position as the largest holding at 18.11% allocation, though its share count decreased slightly by 0.04% during the quarter.
In Healthcare, Bayer AG Spons ADR (BAYRY) and Merck & Co. Inc. (MRK) both saw minor decreases in their share counts (-0.49% and -0.84%, respectively), while Organon & Co (OGN) showed a modest increase (+0.35%).
Walt Disney (DIS) experienced a slight decrease in shares (-0.04%), while Alphabet Inc Class C (GOOG) saw a small increase (+0.52%).
Energy sector holding BP PLC (BP) saw a notable decrease in shares (-4.35%), while Industrials holding Seaboard Corp (SEB) experienced a significant reduction (-5.68%).
Other positions like Flagstar Financial, Inc. (NYCB) and Idt Corp Class B (IDT) also saw decreases (-2.78% and -0.09%), while the portfolio included exposure to smaller companies like Flagstar Financial, Inc. (NYCB) and Idt Corp Class B (IDT).
For detailed insights into Thomas Graham's investment strategy and performance, visit the investor profile: Kahn Brothers Group Investor Profile.
To explore specific stock holdings, including Citigroup (C), Bayer (BAYRY), Merck (MRK), and others, visit: InsiderSet Stock Database.